canertinib has been researched along with pf 573228 in 1 studies
| Studies (canertinib) | Trials (canertinib) | Recent Studies (post-2010) (canertinib) | Studies (pf 573228) | Trials (pf 573228) | Recent Studies (post-2010) (pf 573228) |
|---|---|---|---|---|---|
| 124 | 9 | 65 | 80 | 0 | 72 |
| Protein | Taxonomy | canertinib (IC50) | pf 573228 (IC50) |
|---|---|---|---|
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.743 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.743 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 1 | |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | 0.5985 | |
| Cyclin-H | Homo sapiens (human) | 1 | |
| CDK-activating kinase assembly factor MAT1 | Homo sapiens (human) | 1 | |
| Focal adhesion kinase 1 | Homo sapiens (human) | 0.0563 | |
| Protein-tyrosine kinase 2-beta | Homo sapiens (human) | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
1 other study(ies) available for canertinib and pf 573228
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |